Animal models of arthritis in NOS2-deficient mice

Osteoarthritis and Cartilage

Volumn 7, Issue 4, 1999, Pages 413-415

  Van den Berg, W B ^a   Van de Loo, F ^a   Joosten, L A B ^a   Arntz, O J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arthritis; NO; Osteoarthritis

Indexed keywords

CLOSTRIDIOPEPTIDASE A; NITRIC OXIDE SYNTHASE; PROTEOGLYCAN; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; CARTILAGE DEGENERATION; CONFERENCE PAPER; CONTROLLED STUDY; HISTOPATHOLOGY; JOINT INSTABILITY; KNEE; MOUSE; NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS;

EID: 0033166177     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1999.0228     Document Type: Conference Paper

References (13)

1. van de Loo FAJ, Joosten LAB, van Lent Plem, Arntz OJ, van den Berg WB. Tnf-α and IL-6 in cartilage proteoglycan metabolism and destruction. Arthritis Rheum 1995;38:164-72.
2. van Meurs JBJ, van Lent Plem, Singer II, Bayne EK, van de Loo FAJ, van den Berg WB. Il-1ra prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen induced arthritis. Arthritis Rheum 1998;41:647-56.
3. Verschure PJ, van Marie, Joosten LAB, van den Berg WB. Chondrocyte IGF-receptor expression and reseponsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimental arthritis. Ann Rheum Dis 1995;54:645-53.
4. Macmicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, et al. Altered responses to bacterial infections and endotoxic shock in mice lacking inducible NO synthase. Cell 1995;81:641-50.
5. van de Loo FAJ, Kuiper S,van Enckevort FHJ, Arntz OJ, van den Berg WB. IL-6 reduces cartilage destruction during experimental arthritis. Am J Pathol 1997;151:177-91.
6. van de Loo FAJ, Arntz OJ, van Enckevort FHJ, van Lent Plem, van den Berg WB. Reduced cartilage proteoglycan loss during Zumosan induced gonarthritis in NOS2-deficient mice and in anti-il-1 treated wild type mice with unabated joint inflammation. Arthritis Rheum 1998;41:634-46.
7. Stefanovic-Racic M, Morales Tl, Taskiran D, McLntyre LA, Evans CH. The role of NO in proteoglycan turnover by bovine cartilage organ cultures. J Immunol 1996;156:1213-20.
8. van der Kraan PM, Vitters EL, van Beuningen HM, van de Putte LBA, van den Berg WB. Degenerative knee joint lesions in mice after a single intraarticular collagenase injection. A new model of osteoarthritis. J Exp Pathol 1990;71:19-31.
9. Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, Battista JA, Martel-Pelletier J. Reduced progression of experimental osteoarthritis in vivo by selective inhibition in inducible NO synthase. Arthritis Rheum 1998;41:1275-86.
10. Pelletier JP, Caron JP, Evans C, Robbins PD, Georgescu HI, Jovanovic D, Fernandes JC, Martel-Pelletier J. In vivo suppression of early experimental osteoarthritis by IL-1ra using gene therapy. Arthritis Rheum 1997;40:1012-9.
11. Attur MG, Patel RN, Abramson SB, Amin AR. IL-17 up-regulation of NO production in human osteoarthritic cartilage. Arthritis Rheum 1997;40:1050-3.
12. van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. TGFb stimulates chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994;71:279-90.
13. van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB. Differential effects of local application of BMP-2 and TGFβ1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cart 1998;6:306-17.